Covid vaccines growth is impressive but the volume of doses is a concern: WHO

  • If you look at the number of companies that are announcing positive results in terms of the efficacy of vaccines, that number is increasing. But at the same time ... there are real challenges with volumes. These are still very, very scarce products, the World Health Organization said

ANI
First Published12 Dec 2020
World Health Organization (WHO) is encouraged by the growth in the number of vaccines against COVID-19
World Health Organization (WHO) is encouraged by the growth in the number of vaccines against COVID-19(AFP)

The World Health Organization (WHO) is encouraged by the growth in the number of vaccines against COVID-19 that have performed well in clinical trials, although the organization remains concerned by the limited number of doses currently available, Bruce Aylward, a senior WHO adviser, said on Friday.

A handful of candidate vaccines against COVID-19 have reported efficacy levels of greater than 90 per cent in clinical trials, and Aylward noted that multiple vaccine platforms have shown strong results.

"If you look week by week at the number of companies that are announcing positive results in terms of the efficacy of vaccines, that number is increasing and what's important is it's increasing not just in terms of the number of products, but also the different technology platforms that they are being built on. As we've seen now, there are three different sorts of technology platforms, as we call them, that have reported very positive efficacy and safety data," the WHO senior adviser told a media briefing.

Over the past week, US media outlets reported that Pfizer is unlikely to meet its original supply targets for its vaccine against Covid-19, which is produced in conjunction with German firm BioNTech, due to supply chain issues.

GlaxoSmithKline and Sanofi also announced earlier on Friday that their candidate vaccine will likely not be available until the end of 2021 due to disappointing trial results, and Aylward noted the WHO's concern over the actual number of available vaccine doses.

"But at the same time ... there are real challenges with volumes. These are still very, very scarce products. And just as some companies are announcing successes, there are others - and we've had two over the last few days - that have said they have had challenges with their products either in terms of the volumes they can produce or in terms of some of the trial results," the WHO senior adviser said.

At the same media briefing, WHO Director-General Tedros Adhanom Ghebreyesus expressed his belief that more countries will begin their mass coronavirus disease vaccination programs in the near future. (ANI/Sputnik)

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.MoreLess
HomeNewsIndiaCovid vaccines growth is impressive but the volume of doses is a concern: WHO

Most Active Stocks

Bharat Electronics

309.55
10:29 AM | 14 JUN 2024
8.6 (2.86%)

Indian Oil Corporation

170.30
10:25 AM | 14 JUN 2024
1.2 (0.71%)

HDFC Bank

1,597.45
10:28 AM | 14 JUN 2024
16.55 (1.05%)

State Bank Of India

840.20
10:29 AM | 14 JUN 2024
-3.7 (-0.44%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

JK Paper

490.70
10:25 AM | 14 JUN 2024
44.35 (9.94%)

KRBL

310.05
10:22 AM | 14 JUN 2024
23.05 (8.03%)

Poly Medicure

2,003.00
09:59 AM | 14 JUN 2024
142.9 (7.68%)

KEC International

935.20
10:25 AM | 14 JUN 2024
66.25 (7.62%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    73,303.00-503.00
    Chennai
    73,663.00-143.00
    Delhi
    74,166.00431.00
    Kolkata
    73,016.00-72.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L3.02
    Chennai
    100.75/L0.00
    Kolkata
    103.94/L0.00
    New Delhi
    94.72/L0.00
    OPEN IN APP
    HomeMarketsPremiumInstant LoanGet App